AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2013
Nov 14, 2013
284_dirs_2013-11-14_b2ebf50c-1b1f-4554-83f1-a310b3ec6311.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2013-11-13
Reporting Person: KELLOGG PETER N (Exe V-P & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-13 | Common Stock | M | 40000.0000 | $0.0000 | Acquired | 151631.9020 | Direct |
| 2013-11-13 | Common Stock | F | 20740.0000 | $47.5900 | Disposed | 130891.9020 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-11-13 | Restricted Stock Unit | $ | M | 40000.0000 | Disposed | 2013-11-13 | Common Stock (40000.0000) | Direct |
Footnotes
F1: Holdings include shares acquired in dividend reinvestment transactions.
F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F3: 40,000 Restricted Stock Units vested on November 13, 2010 (reduced by 18,540 withheld for taxes) and 40,000 vested on November 13, 2013 (reduced by 20,740 withheld for taxes).
More from Merck & Co., Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 30